Contact Donald

Speaking Engagements

  

Turbocharge the Development of Best-in-Class Antibody & Cell-Based Approaches of Innate Immune Therapies, to Launch Safe, Globally Scalable & Efficacious Therapies from Europe The momentum of innate immune cell R&D is growing exponentially to harness innate immune responses in oncology, realise scaled allogeneic manufacturing, and drive commercial

18-20 October 2022
  

The 4th Cytokine-Based Drug Development Summit presents an opportunity for cytokine drug developers to explore new possibilities in disease treatment within and beyond oncology. With promising masking and tissue targeting mechanisms and a wealth of preclinical and clinical efficacy data, more companies are receiving funding to enhance their pipelin

27-29 June 2023